What Does SQZ Biotechnologies Do?

Total employees15
HeadquartersWatertown
Founded2013

SQZ Biotechnologies is a clinical-stage biotechnology company focused on developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. The company's proprietary Cell Squeeze® technology enables the physical squeezing of cells through a microfluidic chip, temporarily disrupting the cell membrane to deliver a wide variety of therapeutic cargos, such as mRNA, DNA, proteins, and siRNAs, into the cells with minimal impact on cell health and function. SQZ aims to leverage this platform to create a new generation of cell therapies that can harness the power of a patient's own immune system to fight disease. The company has recently undergone significant restructuring to focus its resources on its most promising programs.

Where Is SQZ Biotechnologies's Headquarters?

SQZ Biotechnologies officeSQZ Biotechnologies officeSQZ Biotechnologies officeSQZ Biotechnologies office
*Images sourced via web search. Rights belong to original owners

HQ Function

Serves as the central hub for research and development, corporate operations, clinical development, and strategic decision-making.

Notable Features:

Modern laboratory and office facilities located within the Arsenal Yards, a contemporary mixed-use development. The facilities are designed to support advanced cell therapy research and manufacturing process development.

Work Culture:

Historically a dynamic, science-driven, and innovative environment. Recent restructuring may have shifted the culture, but the core likely remains focused on scientific excellence and patient impact, albeit with a smaller, more focused team.

HQ Significance:

The Watertown headquarters is strategically positioned within a leading biotech ecosystem, facilitating access to talent, research collaborations, and industry partnerships.

Values Reflected in HQ: The choice of a modern, well-equipped facility in a biotech hub reflects a commitment to innovation, collaboration, and cutting-edge science.

Location:

SQZ Biotechnologies' physical operations are primarily concentrated at its headquarters in Watertown, Massachusetts, USA. While they may engage in global collaborations for clinical trials and research partnerships, they do not maintain significant independent office locations outside of their main HQ. Their focus is on advancing their cell therapy platform and clinical programs, which may involve international sites for trials.

Street Address:

200 Arsenal Yards Blvd, Suite 210

City:

Watertown

State/Province:

MA

Country:

USA

Where Else Does SQZ Biotechnologies Operate Around the World?

No additional office locations available.

Buying Intent Signals for SQZ Biotechnologies

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading SQZ Biotechnologies? Meet the Executive Team

As of April 2025, SQZ Biotechnologies' leadership includes:

Howard Bernstein, M.D., Ph.D. - Interim Chief Executive Officer and Chief Medical Officer
David First - Chief Financial Officer
Scott Raskin, J.D. - General Counsel and Corporate Secretary

Who's Investing in SQZ Biotechnologies?

SQZ Biotechnologies has been backed by several prominent investors over the years, including:

Polaris Partners
GV (Google Ventures)
Roche
New Enterprise Associates (NEA)
Temasek
Ally Bridge Group
Everest Medicines
Indus Valley Partners

What Leadership Changes Has SQZ Biotechnologies Seen Recently?

Hire2
Exits5

SQZ Biotechnologies has undergone significant leadership changes and restructuring in the past 12-18 months, including CEO transition, CFO appointment, and departures of several key executives as part of its strategic realignment.

Departures

Armon Sharei, Ph.D., Armon Sharei transitioned from CEO to a scientific advisory role.
Marshelle Smith Warren, M.D., Marshelle Smith Warren departed as Chief Medical Officer.
Micah Zajic, Micah Zajic departed as Chief Business Officer.
Richard Capasso, J.D., Richard Capasso departed as General Counsel and Corporate Secretary.
Tod Woolf, Ph.D., Tod Woolf, Ph.D., departed as Chief Business Technology Officer.
Patrick Flor, Patrick Flor departed as Chief People Officer.

New Appointments:

Howard Bernstein, M.D., Ph.D., Howard Bernstein appointed as Interim Chief Executive Officer, while retaining his Chief Medical Officer role.
David First, David First appointed as Chief Financial Officer.

What Technology (Tech Stack) Is Used bySQZ Biotechnologies?

Discover the tools SQZ Biotechnologies uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

SQZ Biotechnologies Email Formats and Examples

SQZ Biotechnologies likely uses common corporate email formats. Based on typical patterns and executive contact information, the most probable format is firstinitiallast@sqzbiotech.com.

[first_initial][last]@sqzbiotech.com

Format

hbernstein@sqzbiotech.com

Example

80%

Success rate

What's the Latest News About SQZ Biotechnologies?

GlobeNewswire • April 8, 2024

SQZ Biotechnologies Announces Receipt of Nasdaq Delinquency Letter

SQZ Biotechnologies announced it received a delinquency letter from Nasdaq due to not timely filing its Annual Report on Form 10-K for the year ended December 31, 2023. The company has 60 days to submit a plan to regain compliance....more

GlobeNewswire • November 13, 2023

SQZ Biotechnologies Provides Business Update and Reports Third Quarter 2023 Financial Results

SQZ Biotechnologies provided updates on its strategic priorities, including focusing on the SQZ® eAPC and TAC programs. The company also reported its Q3 2023 financial results and announced the appointment of David First as CFO....more

GlobeNewswire • August 14, 2023

SQZ Biotechnologies Announces Strategic Prioritization and Workforce Reduction

SQZ Biotechnologies announced a strategic prioritization of its clinical programs and a corresponding workforce reduction of approximately 60%, to approximately 15 full-time employees. Founder and CEO Armon Sharei transitioned to a scientific advisory role, with CMO Howard Bernstein appointed Interim CEO....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including SQZ Biotechnologies, are just a search away.